A New Paradigm
in Ophthalmology
and Beyond

—Why we're here

Helping people, through science.
That’s our mission and our pride.

Shaping the future of care through innovation, we are committed to redefining paradigms in ophthalmology and beyond, empowering our partners and their patients with the best, certified medical technologies.

Espansione Group delivers the highest standards in medtech by combining proprietary technologies, like LM™ LLLT photobiomodulation, with a relentless focus on research, development, and customer excellence. With a global presence in over 50 countries, we aim to transform care in ophthalmology and beyond.

> About Us

eye-light® Device is Granted CE (MDR) Mark for Treatment of Dry AMD and Extended Anterior Segment Pathologies

Unlocking New Horizons with Photobiomodulation from the Front to the Back of the Eye

> Posterior Segment

An Ecosystem Harnessing the Power of Light-based Technologies

Our technologies are at the very core of the Espansione Ecosystem—they leverage the power of light and its outstanding ability to benefit the human condition.

They are then seamlessly built into all our solutions, from diagnosis to treatment. We design, craft and test with the greatest attention and care in Italy.

—Ecosystem

Technologies

> LM™ LLLT

> OPE™ IPL

Offerings

Ophthalmology

Anterior Segment

Posterior Segment

Dermatology & Trichology

Solutions

—Benefits

Ecosystem is the term we use to describe the synergy between our technologies and the solutions that leverage on them. Every interaction within the Espansione Ecosystem has been designed to provide both patients’ and operators’ with the best experience possible.

OPHTHALMOLOGY / TREATMENT ↗